343 related articles for article (PubMed ID: 25475597)
1. Advances in the evaluation and management of esophageal disease of systemic sclerosis.
Carlson DA; Hinchcliff M; Pandolfino JE
Curr Rheumatol Rep; 2015 Jan; 17(1):475. PubMed ID: 25475597
[TBL] [Abstract][Full Text] [Related]
2. Abnormal esophageal acid exposure on high-dose proton pump inhibitor therapy is common in systemic sclerosis patients.
Stern EK; Carlson DA; Falmagne S; Hoffmann AD; Carns M; Pandolfino JE; Hinchcliff M; Brenner DM
Neurogastroenterol Motil; 2018 Feb; 30(2):. PubMed ID: 29110377
[TBL] [Abstract][Full Text] [Related]
3. Multimodality evaluation of patients with gastroesophageal reflux disease symptoms who have failed empiric proton pump inhibitor therapy.
Galindo G; Vassalle J; Marcus SN; Triadafilopoulos G
Dis Esophagus; 2013 Jul; 26(5):443-50. PubMed ID: 22862422
[TBL] [Abstract][Full Text] [Related]
4. Esophageal involvement in scleroderma: gastroesophageal reflux, the common problem.
Ntoumazios SK; Voulgari PV; Potsis K; Koutis E; Tsifetaki N; Assimakopoulos DA
Semin Arthritis Rheum; 2006 Dec; 36(3):173-81. PubMed ID: 17045629
[TBL] [Abstract][Full Text] [Related]
5. [Gastrointestinal involvement in systemic sclerosis].
Marie I
Presse Med; 2006 Dec; 35(12 Pt 2):1952-65. PubMed ID: 17159722
[TBL] [Abstract][Full Text] [Related]
6. The effect of endoscopic fundoplication and proton pump inhibitors on baseline impedance and heartburn severity in GERD patients.
Rinsma NF; Farré R; Bouvy ND; Masclee AA; Conchillo JM
Neurogastroenterol Motil; 2015 Feb; 27(2):220-8. PubMed ID: 25348594
[TBL] [Abstract][Full Text] [Related]
7. Lower pH values of weakly acidic refluxes as determinants of heartburn perception in gastroesophageal reflux disease patients with normal esophageal acid exposure.
de Bortoli N; Martinucci I; Savarino E; Franchi R; Bertani L; Russo S; Ceccarelli L; Costa F; Bellini M; Blandizzi C; Savarino V; Marchi S
Dis Esophagus; 2016 Jan; 29(1):3-9. PubMed ID: 25212408
[TBL] [Abstract][Full Text] [Related]
8. Combined esophageal multichannel intraluminal impedance and pH monitoring (MII -pH) in the diagnostics and treatment of gastroesophageal reflux disease and its complications.
Masiak W; Wallner G; Wallner J; Pedowski T; Solecki M
Pol Przegl Chir; 2011 Sep; 83(9):488-96. PubMed ID: 22166737
[TBL] [Abstract][Full Text] [Related]
9. Assessment of esophageal involvement in systemic sclerosis and morphea (localized scleroderma) by clinical, endoscopic, manometric and pH metric features: a prospective comparative hospital based study.
Arif T; Masood Q; Singh J; Hassan I
BMC Gastroenterol; 2015 Feb; 15():24. PubMed ID: 25888470
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic work-up of GERD.
Vela MF
Gastrointest Endosc Clin N Am; 2014 Oct; 24(4):655-66. PubMed ID: 25216910
[TBL] [Abstract][Full Text] [Related]
11. [Esophageal mucosal lesions and scleroderma: prevalence, symptoms and risk factors].
De Castro Parga ML; Alonso P; García Porrua C; Prada JI
Rev Esp Enferm Dig; 1996 Feb; 88(2):93-8. PubMed ID: 8664079
[TBL] [Abstract][Full Text] [Related]
12. Esophageal pH-impedance monitoring in patients with therapy-resistant reflux symptoms: 'on' or 'off' proton pump inhibitor?
Hemmink GJ; Bredenoord AJ; Weusten BL; Monkelbaan JF; Timmer R; Smout AJ
Am J Gastroenterol; 2008 Oct; 103(10):2446-53. PubMed ID: 18684197
[TBL] [Abstract][Full Text] [Related]
13. The many manifestations of gastroesophageal reflux disease: presentation, evaluation, and treatment.
Richter JE
Gastroenterol Clin North Am; 2007 Sep; 36(3):577-99, viii-ix. PubMed ID: 17950439
[TBL] [Abstract][Full Text] [Related]
14. Esophageal function in systemic sclerosis: a prospective evaluation of motility and acid reflux in 36 patients.
Yarze JC; Varga J; Stampfl D; Castell DO; Jimenez SA
Am J Gastroenterol; 1993 Jun; 88(6):870-6. PubMed ID: 8503383
[TBL] [Abstract][Full Text] [Related]
15. National consensus on the management of gastroesophageal reflux disease in Indonesia.
Indonesian Society of Gastroenterology
Acta Med Indones; 2014 Jul; 46(3):263-71. PubMed ID: 25348191
[TBL] [Abstract][Full Text] [Related]
16. Personalized Approach in the Work-up and Management of Gastroesophageal Reflux Disease.
Yadlapati R; Pandolfino JE
Gastrointest Endosc Clin N Am; 2020 Apr; 30(2):227-238. PubMed ID: 32146943
[TBL] [Abstract][Full Text] [Related]
17. [The value of twenty-four hour intraoesophageal pH monitoring and manometry in the management of patients with upper gastrointestinal symptoms].
Lakner L; Döbrönte Z
Orv Hetil; 2009 Oct; 150(43):1978-82. PubMed ID: 19812019
[TBL] [Abstract][Full Text] [Related]
18. High-resolution manometry and impedance-pH/manometry: novel techniques for the advancement of knowledge on esophageal function and their clinical role.
Ciriza-de-Los-Ríos C; Canga-Rodríguez-Valcárcel F
Rev Esp Enferm Dig; 2009 Dec; 101(12):861-9. PubMed ID: 20082547
[No Abstract] [Full Text] [Related]
19. An algorithm for diagnosis and treatment of refractory GERD.
Hershcovici T; Fass R
Best Pract Res Clin Gastroenterol; 2010 Dec; 24(6):923-36. PubMed ID: 21126704
[TBL] [Abstract][Full Text] [Related]
20. Proton pump inhibitor responders who are not confirmed as GERD patients with impedance and pH monitoring: who are they?
de Bortoli N; Martinucci I; Savarino E; Bellini M; Bredenoord AJ; Franchi R; Bertani L; Furnari M; Savarino V; Blandizzi C; Marchi S
Neurogastroenterol Motil; 2014 Jan; 26(1):28-35. PubMed ID: 23992024
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
